- Home
- SMA vs JANX Comparison
SMA vs JANX Comparison
Compare SMA & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMA
- JANX
- Stock Information
- Founded
- SMA 2013
- JANX 2017
- Country
- SMA United States
- JANX United States
- Employees
- SMA N/A
- JANX N/A
- Industry
- SMA
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- SMA
- JANX Health Care
- Exchange
- SMA NYSE
- JANX Nasdaq
- Market Cap
- SMA 1.8B
- JANX 1.6B
- IPO Year
- SMA 2025
- JANX 2021
- Fundamental
- Price
- SMA $36.45
- JANX $23.80
- Analyst Decision
- SMA Strong Buy
- JANX Strong Buy
- Analyst Count
- SMA 6
- JANX 7
- Target Price
- SMA $38.33
- JANX $94.29
- AVG Volume (30 Days)
- SMA 382.8K
- JANX 1.3M
- Earning Date
- SMA 05-07-2025
- JANX 05-08-2025
- Dividend Yield
- SMA 0.73%
- JANX N/A
- EPS Growth
- SMA N/A
- JANX N/A
- EPS
- SMA N/A
- JANX N/A
- Revenue
- SMA $235,799,000.00
- JANX $9,336,000.00
- Revenue This Year
- SMA N/A
- JANX N/A
- Revenue Next Year
- SMA N/A
- JANX $283.88
- P/E Ratio
- SMA N/A
- JANX N/A
- Revenue Growth
- SMA 5.34
- JANX 28.12
- 52 Week Low
- SMA $29.89
- JANX $22.48
- 52 Week High
- SMA $37.74
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- SMA N/A
- JANX 39.00
- Support Level
- SMA N/A
- JANX $23.52
- Resistance Level
- SMA N/A
- JANX $26.46
- Average True Range (ATR)
- SMA 0.00
- JANX 1.79
- MACD
- SMA 0.00
- JANX -0.00
- Stochastic Oscillator
- SMA 0.00
- JANX 27.53
About SMA SMARTSTOP SELF STORAGE REIT INC
Smartstop Self Storage REIT Inc operates as a real estate investment trust. The trust owns, acquires, and operates self-storage properties. It operates in two segments namely, self-storage operations which generates key revenue, and managed REIT platform business. The investment objective is to focus on investing in self-storage facilities and related self-storage real estate investments that are expected to support sustainable stockholder distributions over the long term.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.